Latest Multiple drug resistance Stories
For bacteria in wastewater treatment plants, the stars align perfectly to create a hedonistic mating ground for antibiotic-resistant superbugs eventually discharged into streams and lakes.
Inhibiting the "drug efflux pumps" in bacteria, which function as their defence mechanisms against antibiotics, can mask the effect of mutations that have led to resistance in the form of low-affinity drug binding to target molecules in the cell.
Unique GeneXpert(R) System Capabilities Enable Powerful New TB Diagnostic Tool SUNNYVALE, Calif., April 27 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the release of Xpert(R) MTB/RIF as a CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices.
- Wiggins Joins from Biogen Idec - SAN DIEGO, April 20 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced that Mark Wiggins has joined the company as Chief Business Officer. Mr. Wiggins comes to Mpex from Biogen Idec, Inc.
Residents of nursing homes are one of the main reservoirs of anti-microbial resistant bacteria, U.S. researchers said. Study leader Dr.
A research team at the Scripps Research Institute has obtained the first glimpse of a protein that keeps certain substances, including many drugs, out of cells. The protein, called P-glycoprotein or P-gp for short, is one of the main reasons cancer cells are resistant to chemotherapy drugs.
PARIS, March 26 /PRNewswire-FirstCall/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today the appointment of Dr.
WASHINGTON, March 17 /PRNewswire-USNewswire/ -- Keep Antibiotics Working (KAW) -- a national coalition of health, consumer, agricultural, environmental, humane, and other advocacy groups with more than ten million supporters -- today welcomed the reintroduction of a bill that would help combat the antibiotic resistance crisis by targeting the overuse of antibiotics important to human medicine in animal agriculture.
Product Candidate NVC-422 Demonstrates Ability to Treat Subcutaneous Infections EMERYVILLE, Calif., March 4 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc.
SAN DIEGO, Feb. 10 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced that it has completed a $27.5 million initial closing of a Series D financing led by Investor Growth Capital.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.